Ozempic Cost 2026: List Price, Insurance, Self-Pay

How Much Does Ozempic Cost? The Numbers at a Glance

The short answer most people want: Ozempic's list price runs in the $900–$1,000+ range, and Novo Nordisk's own pricing page shows a current, exact figure of $1,027.51 per pen regardless of which of the four approved strengths (0.25 mg, 0.5 mg, 1 mg, or 2 mg) is prescribed. Almost no one pays that full amount. What you actually spend depends on which pathway below fits your coverage. Ozempic cost is really a set of prices, not one number, and the table maps the routes you're likely to run into.

The four price points patients actually hit: list price, established self-pay, new-patient self-pay, and the savings-card floor.

Why the price is the same no matter which dose you're on

Ozempic's standard titration climbs from 0.25 mg to 0.5 mg to a 1 mg maintenance dose, with an optional 2 mg step approved in 2024 for extra glycemic control. Yet the list price does not track the milligram amount. Each of the four strengths carries the same $1,027.51 wholesale figure because the pen and box are what the pharmacy bills, not the dose inside it. The only place dose changes your bill is on the NovoCare self-pay ladder, where the 2 mg tier sits a step above the lower doses.

Ozempic Cost With Commercial Insurance

Because Ozempic is approved for type 2 diabetes, a long-established indication, most commercial formularies cover it, usually on a higher tier and almost always behind a prior authorization. Once your plan approves the claim, your Ozempic cost drops to a plan copay rather than the list price, and the manufacturer savings card can take that copay lower still.

The Ozempic Savings Card can bring eligible, commercially insured patients down to as little as $25 per fill, for up to a 3-month prescription. It works only for patients whose commercial plan covers the drug, and government-insured patients (Medicare, Medicaid, TRICARE) do not qualify. For the full mechanics, the monthly savings cap, program length, and who qualifies, see the Ozempic Savings Card guide. This page stays on the broader price picture.

Ozempic Cost Without Insurance

No coverage does not mean paying the full $1,027.51. Novo Nordisk runs a direct self-pay pharmacy, and third-party discount cards give you a second number to compare against.

NovoCare self-pay pricing (2026)

NovoCare is Novo Nordisk's direct-to-patient pharmacy, and it prices Ozempic in tiers. New patients pay $199 per month on the 0.25 mg and 0.5 mg starter doses, covering the first two monthly fills, as an introductory rate running through the end of 2026. Established patients pay $349 per month on the 0.25 mg through 1 mg doses, and $499 per month on the 2 mg dose. Self-pay cannot be combined with insurance, and terms are set by the manufacturer, so confirm the current rate at ozempic.com or novocare.com before you rely on it.

A newer federal drug-pricing portal, TrumpRx.gov, now lists Ozempic and mirrors these same self-pay tiers alongside the $1,027.51 original list price. It is a self-pay discount comparison point that requires no government insurance, not a Medicare benefit, so read it as one more place to check the cash price rather than a coverage program.

GoodRx and retail discount cards

GoodRx, SingleCare, and similar services aggregate retail pharmacy discounts. The prices they quote shift by ZIP code, by pharmacy, and over time, so a number you find today may not hold at the counter next month. They are worth pricing against the NovoCare self-pay rate, especially if you do not qualify for the savings card. Ozempic cost at commonly searched retailers like Costco or Walmart varies the same way, and no chain publishes a fixed cash price you can bank on, so pull a live quote for your exact prescription and ZIP.

Does Medicare Cover Ozempic?

Medicare Part D can cover Ozempic when it is prescribed for type 2 diabetes, and covered patients benefit from the annual Part D out-of-pocket cap introduced by the Inflation Reduction Act redesign. The cap is indexed and rises each year: $2,000 in 2025, $2,100 in 2026 and $2,400 in 2027 (CMS and Medicare.gov, checked October 2, 2026). That cap can be the single biggest cost lever for a Medicare patient on Ozempic for diabetes.

The exception is weight loss. Part D does not cover GLP-1 medications prescribed specifically for obesity, an exclusion written into the statute at Social Security Act Section 1860D-2(e)(2)(A). That is why a drug like Wegovy for obesity is not a Part D benefit, while Ozempic for diabetes can be. The separate CMS Medicare GLP-1 Bridge (July 1, 2026 to December 31, 2027) covers Wegovy, the Zepbound KwikPen and Foundayo, but not Ozempic. For the full Wegovy-and-Medicare breakdown, see the semaglutide cost guide rather than re-reading it here.

Type 2 Diabetes vs Off-Label Weight Loss: Why Coverage and Cost Differ

This is the distinction that drives most of what you pay. Ozempic is FDA-approved for type 2 diabetes, first cleared in December 2017. Insurers pay claims against that on-label diagnosis code, so a patient with type 2 diabetes usually gets coverage, while a patient prescribed Ozempic off-label for weight loss usually does not, and lands in self-pay territory instead.

There is a clinical wrinkle too. Ozempic's approved maximum is 1 mg standard, or 2 mg optional, which is lower than Wegovy's 2.4 mg weight-management protocol. So an off-label Ozempic user is typically paying out of pocket and dosing below the level studied for weight loss.

The diagnosis on the prescription decides most of the outcome: diabetes tends to be covered; off-label weight loss tends to be self-pay.

Why Ozempic's Price Varies Month to Month

Patients often report the number moving between fills, and there are four ordinary reasons for it, none of them unique to Ozempic.

• Plan-year resets. Formularies, tiers, and deductibles change every January, so the same prescription can cost more in the first quarter before a deductible is met.
• Pharmacy-to-pharmacy variance. Discount-card prices differ by pharmacy and ZIP code, so two counters a few miles apart can quote different cash prices on the same day.
• Time-bound manufacturer terms. The savings card and the self-pay offers are set by Novo Nordisk and carry expiration dates, so an introductory rate can change when the program period ends.
• Periodic list-price increases. Drug wholesale prices generally rise on an annual cadence, which nudges the underlying list figure over time.

So re-check your price at each refill rather than assuming last quarter's number still holds.

Ozempic Cost vs Other Brands

At brand-name list price, Ozempic sits in the same neighborhood as its main competitor, Mounjaro, and both cost less than Wegovy. The differences that matter show up at the self-pay floor and in which indication each drug is covered for. Rather than rebuild that table here, the Ozempic vs Mounjaro comparison covers the brand-to-brand list-price picture, and the semaglutide cost guide lays out the full Ozempic, Wegovy, and tirzepatide cost stack side by side.

Is the Cost Worth It? A Quick Pharmacokinetics Note

The value question on a GLP-1 is not what you weigh this month against what you paid this month. Semaglutide's half-life is about 7 days, so a steady-state blood level only builds out after roughly four to five weeks at each dose, and the clinical benefit accrues across many months. A single fill is one point on that curve, not the whole return.

If you are weighing a cheaper month against a slower titration or a pause, the useful lens is the cumulative exposure you are buying, not the invoice in isolation. The semaglutide cost calculator breaks a pen price down per month, week, and milligram, and the semaglutide calculator models the dose curve at any schedule, which helps if you are timing a step-down to manage cost without unraveling steady state.